Novartis AG is 205.8x more valuable than Septerna, Inc. by market capitalization ($282.64 B vs $1.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SEPN | NVS |
|---|---|---|
| Market cap | $1.37 B | $282.64 B |
| US-listed rank | #2396 | #47 |
| Revenue (latest FY) | $45.95M | - |
| Net income (latest FY) | -$48.88M | - |
| Net margin | -106.4% | - |
| SEC filings | 129 | 947 |
Novartis AG is 205.8x more valuable than Septerna, Inc. by market capitalization ($282.64 B vs $1.37 B).
Full pages: Septerna, Inc. and Novartis AG, or browse the full rankings.